Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank80
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-10.71%
↑ 87% vs avg
Percentile
P80
Within normal range
Streak
4 yr
Consecutive growthAccelerating
Average
-83.57%
Historical baseline
PeriodValue
2024-10.71%
2023-34.50%
2022-38.99%
2021-78.08%
2020-339.13%
20190.00%